If you’ve ever stared at your migraine medication cabinet wondering if there’s a better fit, you’re not alone. Millions of people living with chronic migraine try Ajovy, only to find it doesn’t work for their body, causes unwanted side effects, or doesn’t fit their budget. That’s why researching 5 Alternatives for Ajovy is one of the most common questions migraine patients bring to their neurologists every month.

Migraine isn’t just a bad headache. For 1 in 7 people worldwide, it’s a disabling neurological condition that steals work days, family time, and basic peace of mind. While CGRP inhibitors like Ajovy revolutionized treatment starting in 2018, they don’t work for 40% of people who try them. You don’t have to settle for unmanageable pain or side effects that feel worse than the migraines themselves.

In this guide, we’ll break down each alternative with clear, unbiased details on effectiveness, side effects, dosing, and who each option works best for. We won’t push any one treatment—we’ll give you the facts you need to have an informed conversation with your doctor. No medical jargon, no hidden agendas, just real information for people living with migraine.

1. Emgality: Closest Mechanism Alternative To Ajovy

Emgality is another CGRP monoclonal antibody, meaning it targets the exact same migraine pathway as Ajovy. This makes it the most common first alternative doctors suggest when Ajovy doesn’t work for a patient. Unlike Ajovy which is dosed every 3 months after loading doses, Emgality is taken once monthly. A 2023 head-to-head study found that 52% of people who didn’t respond to Ajovy saw a 50% or greater reduction in migraine days after switching to Emgality.

Many patients notice subtle differences between the two medications even though they work the same way. Side effect profiles are very similar, but most people report less injection site reaction with Emgality. Common side effects include:

• Mild redness or itching at the injection site
• Temporary fatigue for 1-2 days after dosing
• Mild joint stiffness

All of these side effects typically resolve within the first 3 months of consistent use for most users.

When considering this option, it’s important to note that insurance coverage works almost identically for both drugs. Most plans require you try one CGRP inhibitor before approving another, so Emgality is almost always the next step in coverage. You will still complete a loading dose period when first starting, just like you did with Ajovy.

This alternative works best for people who saw partial improvement with Ajovy, but didn’t get the full relief they needed. It’s also a good pick if you prefer monthly dosing over the every-3-month schedule Ajovy uses. Talk to your neurologist about waiting at least 12 weeks after your last Ajovy dose before making the switch to get an accurate read on effectiveness.

2. Aimovig: Longest Track Record Of All CGRP Inhibitors

Aimovig was the very first CGRP inhibitor approved for migraine prevention, so it has more than 10 years of real world patient data available. That long track record makes it a reliable pick for many patients and doctors alike. It targets the CGRP receptor, rather than the CGRP molecule itself, which is the small chemical difference that makes it work differently for some people.

Dosing for Aimovig is once monthly, with no loading doses required for most adults. One of the biggest reported benefits over Ajovy is more consistent month-over-month relief. A 2024 patient survey of 12,000 migraine patients found the following satisfaction rates:

Treatment	Patient Satisfaction Score (1-10)
Aimovig	7.2
Ajovy	6.8
Emgality	7.0

This small difference adds up for people who have tried multiple treatments without luck.

The most common side effect with Aimovig is constipation, which affects roughly 12% of users. Most people manage this with increased water intake and over the counter fiber supplements. Unlike Ajovy, Aimovig has not been associated with the temporary hair thinning that a small percentage of patients report.

This is the best alternative for people who experienced bad side effects with Ajovy, or who saw no improvement at all after a full 3 month trial. It is also frequently prescribed for people who have both migraine and cluster headaches, as it has formal approval for both conditions.

3. Vyepti: Intravenous Alternative For Severe Migraine

Vyepti is the only intravenous CGRP inhibitor on the market, which means you receive it via an infusion at a doctor’s office every 3 months. For many people who hate self-injecting at home, this is a huge benefit. It also has the fastest onset of action of all the medications in this class, with many patients reporting improvement within 3 days of their first infusion.

Because it is administered intravenously, the entire dose enters your system at once, rather than being absorbed slowly over time under the skin. Clinical trials found that 61% of patients using Vyepti had at least half their migraine days eliminated, compared to 53% for Ajovy. When considering Vyepti, remember these key differences:

1. You will spend 30-45 minutes at an infusion center for each dose
2. Insurance pre-authorization usually takes 7-14 days
3. No at home injections are ever required
4. Side effects during infusion are extremely rare

The biggest downside for most people is the time commitment. Unlike Ajovy which you can inject at home in 10 seconds, Vyepti requires travel and waiting time at a clinic. That said, many patients say the improved relief is well worth the 4 visits per year.

This alternative is ideal for people who have failed 2 or more injectable CGRP inhibitors, or who cannot tolerate self injections due to needle phobia or hand mobility issues. It is also the first line alternative recommended for people with chronic migraine that causes 15 or more headache days per month.

4. Nurtec ODT: Oral Daily Prevention Alternative

If you want to move away from injectable medications entirely, Nurtec ODT is one of the most popular alternatives to Ajovy. It is an oral tablet that dissolves under your tongue, taken once every other day for migraine prevention. Unlike older oral migraine preventatives, it does not cause weight gain, brain fog, or fatigue for most users.

Nurtec works as both a prevention medication and an abortive treatment, meaning you can also take an extra dose if you feel a migraine starting. This dual action is the biggest advantage it has over injectable options like Ajovy. Roughly 47% of patients on Nurtec report a 50% reduction in migraine days, which is comparable to results seen with Ajovy.

Most people adjust to Nurtec within the first two weeks. The most common reported side effects are mild nausea when first starting, and occasional dry mouth. Unlike Ajovy, you can stop and start Nurtec at any time with no withdrawal effects. This makes it a good option to test before committing to a longer acting injectable medication.

This is the right pick for people who do not want to use injectable medications, who prefer the flexibility of an oral treatment, or who want one medication that works for both prevention and attack treatment. It is also approved for use in teenagers 12 and older, which is not the case for Ajovy.

5. Atogepant: Newest Oral Preventative With Flexible Dosing

Atogepant is the newest oral CGRP inhibitor approved for migraine prevention, and it has quickly become one of the most requested Ajovy alternatives. It is taken once daily, and comes in three different dose strengths so your doctor can adjust your treatment exactly to your needs.

Clinical trials for Atogepant showed some of the strongest results in the entire class. For people with chronic migraine, 59% of trial participants saw a 50% or greater reduction in monthly migraine days. Importantly, 31% of participants reported zero migraine days for at least one full month during the trial period. When starting Atogepant, your doctor will typically follow this titration schedule:

• Weeks 1-2: 10mg once daily
• Weeks 3-4: 30mg once daily
• After week 4: Adjust up to 60mg if needed

This slow titration almost eliminates the nausea that is common with other oral CGRP medications.

Side effects are very mild for most people. Less than 5% of users report any side effects that cause them to stop the medication. The most common ones are mild fatigue and occasional constipation. Unlike Ajovy, Atogepant has no known interactions with most common prescription medications including birth control, blood pressure drugs, and antidepressants.

This alternative is the best choice for people who tried Ajovy and got only mild relief, or who want the flexibility of adjusting their dose as their migraine patterns change. It is also a good option for people who experience migraine with aura, as it has shown particularly good results for this subgroup of patients.

At the end of the day, there is no perfect migraine medication that works for every single person. The 5 alternatives for Ajovy we covered here each have unique benefits, tradeoffs, and ideal use cases. What works for your friend or family member might not work for you, and that is completely normal. Migraine treatment is always a process of trial and error, even with the most modern medications available.

Before making any changes to your treatment plan, always schedule a conversation with your neurologist. Bring this list, write down your experiences with Ajovy, and be honest about what matters most to you—whether that’s less injections, fewer side effects, or better overall relief. Don’t be afraid to ask questions, and remember: you don’t have to settle for migraine control that feels less than good enough.